Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
WILSON VIRGINIA M | Director | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Virgina M. Wilson | 2025-05-23 | 0001262696 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRL | Common Stock | Award | $128K | +946 | +23.86% | $134.98 | 4.91K | May 21, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRL | Stock Options (Right to Buy) | Award | $280K | +2.08K | $134.98 | 2.08K | May 21, 2025 | Common Stock | 2.08K | $134.98 | Direct | F2 |
Id | Content |
---|---|
F1 | The unvested restricted stock units vest upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders. |
F2 | The stock options become exercisable upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders. |